Quick Umbrellux DAO Test Reveals If That Reaction Is Really Histamine Intolerance And Not A Food Allergy
May 13, 2019 09:30 ET
|
Umbrellux DAO
ANN ARBOR, Mich., May 13, 2019 (GLOBE NEWSWIRE) -- Food Allergy Awareness Week is the perfect time to determine if you may be mislabeling your body’s reaction to certain foods. Umbrellux DAO offers...
Intrommune Therapeutics Announces Grant of European Patent Covering Oral Mucosal Immunotherapy for Food Allergy
March 08, 2019 10:01 ET
|
Intrommune Therapeutics
New York, March 08, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is...
US BioTek Laboratories Announces Jack Frausing as CEO
January 14, 2019 08:00 ET
|
US BioTek
SEATTLE, Jan. 14, 2019 (GLOBE NEWSWIRE) -- US BioTek Laboratories (US BioTek) announced today the appointment of a new President and CEO, Jack Frausing. Frausing assumes the leadership from...
Intrommune Therapeutics Announces First Close of Series A Preferred Equity Financing and Successful Close of Crowdfunding Financing Campaign to Support New Peanut Allergy Treatment
November 08, 2018 16:44 ET
|
Intrommune Therapeutics
New York, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is...
Intrommune Therapeutics Completes Pre-IND Meeting With FDA on INT301 for Peanut Allergy
September 06, 2018 07:11 ET
|
Intrommune Therapeutics
New York, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biopharmaceutical company developing a patient-friendly immunotherapy platform for the treatment of food...
Intrommune Therapeutics Submits Pre-IND Meeting Request to the U.S. FDA for INT301, Its Peanut Allergy Oral Mucosal Immunotherapy Drug Candidate, During Food Allergy Awareness Week
May 15, 2018 12:00 ET
|
Intrommune Therapeutics
New York, May 15, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a NYC-based biopharmaceutical company developing a patient-friendly immunotherapy platform for the treatment of food...
Intrommune Therapeutics Announces Crowdfunding Financing Campaign to Support Food Allergy Treatment Research
May 09, 2018 10:36 ET
|
Intrommune Therapeutics
New York, May 09, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics is pleased to announce the launch of a crowdfunding campaign on the Netcapital platform. This campaign supports the next steps of...
Intrommune Therapeutics to Present at Eighth Annual BioNJ BioPartnering Conference
April 24, 2018 09:27 ET
|
Intrommune Therapeutics
New York, April 24, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a biopharmaceutical company developing a patient-friendly platform for the treatment of food allergies, announced today that it...
YumEarth Organic Candy Corn Brings About Smiles for Halloween
October 18, 2017 09:10 ET
|
YumEarth
STAMFORD, Conn., Oct. 18, 2017 (GLOBE NEWSWIRE) -- After a successful trial run in 2016, YumEarth is officially launching the nation's first USDA Certified Organic Candy Corn leading up to...
Allergy Partners: Will My Food Allergy Go Away?
September 07, 2017 03:00 ET
|
Allergy Partners
ASHEVILLE, N.C., Sept. 07, 2017 (GLOBE NEWSWIRE) -- As allergy specialists, we are often asked this question by our patients, but the answer can be more complicated than it seems. Food allergy is...